The blood levels of non-high density lipoprotein cholesterol were found to have a strong association with the long-term risk for a cardiovascular disease event.
The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.
The hepatocyte-directed antisense oligonucleotide AKCEA-APO(a)-LRx was found to lower in a dose-dependent manner lipoprotein(a) levels in patients with elevated lipoprotein(a) levels and established cardiovascular disease.
Reducing the daily eating window from ≥14 hours to a self-selected 10-hour window may lead to weight loss and a decrease in metabolic risk factors.
Low HDL-C may be used to monitor long-term average triglycerides and remnant cholesterol levels, similar to how high hemoglobin A1c is used to monitor long-term elevated glucose levels.
Pharmacist-led interventions in general practice can significantly reduce medical risk factors associated with cardiovascular events.
The study demonstrated a mechanism of statins can induce onset of diabetes.
Twice-yearly dosing with inclisiran sodium resulted in significant lowering of low-density lipoprotein cholesterol.
Several clinical features can be accurate in differentiating between familial chylomicronemia syndrome and severe hypertriglyceridemia.
One-third of patients with diabetes and HTG overall and approximately 40% of statin users were found to be at high long-term cardiovascular risk.